Capula Management’s Elevance Health ELV Stock Holding History

Capula Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-900	Closed	-$263K	–	841
2026 Q1	$263K	Buy	900 +500	+125%	+$164K	﹤0.01%	672
2025 Q4	$140K	Buy	400 +200	+100%	+$67.6K	﹤0.01%	661
2025 Q3	$64.6K	Sell	200 -200	-50%	-$62.2K	﹤0.01%	752
2025 Q2	$156K	Hold	400	–	–	﹤0.01%	424
2025 Q1	$174K	Buy	+400	New	+$161K	﹤0.01%	550
2023 Q1	–	Sell	-7,000	Closed	-$3.59M	–	767
2022 Q4	$3.59M	Buy	+7,000	New	+$3.55M	0.05%	291
2022 Q3	–	Sell	-3,200	Closed	-$1.54M	–	611
2022 Q2	$1.54M	Buy	+3,200	New	+$1.58M	0.03%	268
2021 Q4	–	Sell	-3,400	Closed	-$1.27M	–	388
2021 Q3	$1.27M	Sell	3,400 -8,200	-71%	-$3.12M	0.02%	489
2021 Q2	$4.43M	Sell	11,600 -7,300	-39%	-$2.79M	0.07%	209
2021 Q1	$6.78M	Buy	18,900 +11,000	+139%	+$3.54M	0.13%	171
2020 Q4	$2.54M	Buy	+7,900	New	+$2.42M	0.13%	154

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capula Management's ELV Position: Q2 2026 in Review

Capula Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 250 shares — an estimated $73.2K sold.

Capula Management first reported a position in ELV in Q4 2020 and held it in 14 quarters. The position peaked at $2.43M in Q4 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Capula Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Capula Management sold 250 Elevance Health shares in Q2 2026, an estimated $73.2K.
Capula Management first reported a position in Elevance Health in Q4 2020 and held it in 14 quarters.
Capula Management's Elevance Health position peaked at $2.43M in Q4 2022.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.